葛兰素史克(US)(GSK)股吧_葛兰素史克(US)怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
49	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-19 11:58
56	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-19 09:08
93	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-14 08:00
881	2	葛兰素史克抗癌药物Blenrep显著降低死亡风险有望重获监管批准	葛兰素史克(US)资讯	11-14 05:00
404	0	百年传奇肝素药物，辉瑞、赛诺菲等巨头角逐，最新市场趋势分析！	摩熵医药	11-14 03:32
95	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-13 11:19
107	0	[Amend] Statement of Beneficial Ownership by Certain Investors	葛兰素史克(US)资讯	11-13 05:44
107	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-12 11:38
108	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-12 10:48
305	0	GSK中国疫苗医学负责人和云鹍：重磅产品加速落地提升成人疫苗创新可及	葛兰素史克(US)资讯	11-09 04:10
340	0	专访GSK副总裁、中国疫苗业务负责人李卫东：推动疫苗处方走深走实，深化医防融合	葛兰素史克(US)资讯	11-07 03:36
301	0	看跨国药械企业如何用创新方案践行中国承诺 \| 聚焦进博会	葛兰素史克(US)资讯	11-06 08:40
313	0	（第七届进博会）葛兰素史克中国总经理余慧明：在进博会看到中国未来发展的确定性	葛兰素史克(US)资讯	11-05 10:33
183	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	11-01 11:32
669	0	8.5亿美元收购成都创新药或将破解红斑狼疮！	川商传媒	10-31 02:21
180	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-31 01:22
187	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-31 12:20
3096	0	GSK再度来华收购创新药！签下8.5亿美元协议拓展红斑狼疮管线	葛兰素史克(US)资讯	10-29 10:46
229	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-24 07:41
556	0	穿越周期 GSK中国区“新帅”谈如何把握中国市场	葛兰素史克(US)资讯	10-24 03:55
259	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-18 12:40
246	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-17 04:03
231	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-16 06:27
229	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-15 06:40
233	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-15 06:16
223	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-12 12:01
226	1	RSV疫苗，即呼吸道合胞病毒疫苗，是一种用于预防呼吸道合胞病毒（RSV）感染的疫	Temp444	10-11 09:46
224	0	全球首款RSV疫苗是由葛兰素史克（GSK）公司研发的。该公司研发的Arexvy疫	Temp444	10-11 09:45
221	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-10 11:06
451	0	葛兰素史克同意支付高达22亿美元解决约8万起胃灼热药物Zantac有关诉讼案	葛兰素史克(US)资讯	10-10 11:12
222	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-10 01:46
980	0	葛兰素史克将以高达22亿美元的价格解决ZANTAC产品责任案件	葛兰素史克(US)资讯	10-10 12:54
211	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	10-08 09:29
784	0	杰富瑞将葛兰素史克目标价下调至53美元	葛兰素史克(US)资讯	10-03 11:25
613	0	葛兰素史克中国疫苗业务负责人确定	葛兰素史克(US)资讯	09-25 08:52
228	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-24 11:11
232	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-24 06:12
460	0	葛兰素史克就两起与胃灼热药物Zantac有关的诉讼达成和解	葛兰素史克(US)资讯	09-18 11:57
241	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-18 09:27
274	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-17 07:13
341	0	“长效”并不一定等于“有效”	A股蜻蜓队长	09-14 03:12
249	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-13 06:31
1725	4	默沙东市值2万亿人民币，葛兰素史克市值六千多亿人民币，一个零头就能买下智飞生物。	世界股尊	09-12 12:16
269	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-12 10:59
254	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-12 06:37
279	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-12 01:46
263	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-11 10:52
270	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-11 07:06
271	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-09 10:00
280	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-06 11:16
256	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-06 06:16
263	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	09-03 06:20
256	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-29 07:05
406	1	FDA批准扩大葛兰素史克RSV疫苗的使用范围到50至59岁的成年人	格隆汇	06-11 11:15
253	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-28 09:37
231	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-28 09:27
235	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-28 07:47
577	0	100%患者持久无癌！GSK抗PD-1单抗新药启动中国2期临床	恒生医疗ETF	08-22 07:27
247	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-21 11:28
406	1	资金实力，研发实力，与国际巨头的合作经验等足以确保智飞生物是未来中国疫苗出海的头	世界股尊	08-21 09:25
245	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-20 11:48
242	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-20 06:57
275	3	周末大事件#周度策略##复盘记录##股市怎么看##收盘点评##周末杂谈#	世界股尊	08-18 09:31
257	1	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-16 06:47
590	0	全球超170个乙肝新药研发竞速，GSK、东阳光突破性疗法助力乙肝治愈	摩熵医药	08-15 06:22
314	1	学术丨《Nature》子刊:重组带状疱疹疫苗预防超过17%失智症风险!	医药智投	08-15 08:37
9378	13	从300杀到20，宫颈癌疫苗大乱斗	诗与星空	08-14 07:05
264	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-12 11:26
269	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-06 08:01
268	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-02 07:58
252	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-01 10:46
532	0	葛兰素史克称其带状疱疹疫苗可降低阿尔茨海默症相关风险能否成为药物之外的新方向？	葛兰素史克(US)资讯	08-01 05:48
205	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	08-01 12:47
230	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	07-29 06:36
217	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	07-29 06:29
425	0	葛兰素史克副总裁、葛兰素史克中国总经理余慧明：一流营商环境坚定跨国企业信心	葛兰素史克(US)资讯	07-22 05:42
265	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	07-19 07:27
254	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	07-19 12:36
243	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	07-17 09:43
236	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克(US)资讯	07-16 02:07

emytylist